I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Case Report: Anlotinib combined with PD-1 inhibitor and seq..:
Yunpeng Wang
;
Bofang Wang
;
Lin Xiang
...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.1016647/full. , 2022
Link:
https://doi.org/10.3389/fimmu.2022.1016647
RT Journal T1 <Title>Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:dde48c2378a546038e10afd2aed565ca&Exemplar=1&LAN=DE A1 Yunpeng Wang A1 Bofang Wang A1 Lin Xiang A1 Junge Deng A1 Bo Xu A1 Puyi He A1 Weigao Pu A1 Haiyun Wang A1 Yong Fan A1 Hao Chen PB Frontiers Media S.A. YR 2022 K1 Anlotinib K1 PD-1 inhibitor K1 chemotherapy K1 metastatic pancreatic ductal adenocarcinoma K1 KRAS K1 case report K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2022.1016647/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2022.1016647 DO https://doi.org/10.3389/fimmu.2022.1016647 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
